SLBT
Income statement / Annual
Last year (2025), SL Science Holdi's total revenue was $2.20 M,
a decrease of 34.68% from the previous year.
In 2025, SL Science Holdi's net income was -$3.82 M.
See SL Science Holdi,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
| Operating Revenue |
$2.20 M |
$3.36 M |
$878.97 K |
| Cost of Revenue |
$1.42 M
|
$1.43 M
|
$140.96 K
|
| Gross Profit |
$775.06 K
|
$1.93 M
|
$738.01 K
|
| Gross Profit Ratio |
0.35
|
0.57
|
0.84
|
| Research and Development Expenses |
$2.07 M
|
$2.02 M
|
$0.00
|
| General & Administrative Expenses |
$2.54 M
|
$1.11 M
|
$606.92 K
|
| Selling & Marketing Expenses |
$0.00
|
$1.20 K
|
$34.26 K
|
| Selling, General & Administrative Expenses |
$2.54 M
|
$1.11 M
|
$641.18 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$4.61 M
|
$3.13 M
|
$641.18 K
|
| Cost And Expenses |
$6.03 M
|
$4.56 M
|
$782.14 K
|
| Interest Income |
$40.30 K
|
$45.30 K
|
$1.61 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$93.69 K
|
$47.25 K
|
$37.19 K
|
| EBITDA |
-$3.74 M |
-$1.15 M |
$134.02 K |
| EBITDA Ratio |
-1.7
|
-0.34
|
0.15
|
| Operating Income Ratio |
-1.75
|
-0.36
|
0.11
|
| Total Other Income/Expenses Net |
$17.67 K
|
$62.41 K
|
$436.04 K
|
| Income Before Tax |
-$3.82 M
|
-$1.13 M
|
$532.87 K
|
| Income Before Tax Ratio |
-1.74
|
-0.34
|
0.61
|
| Income Tax Expense |
-$4.00
|
$57.64 K
|
$133.84 K
|
| Net Income |
-$3.82 M
|
-$1.19 M
|
$399.04 K
|
| Net Income Ratio |
-1.74
|
-0.35
|
0.45
|
| EPS |
0 |
0 |
0 |
| EPS Diluted |
0 |
0 |
0 |
| Weighted Average Shares Out |
$0.00
|
$0.00
|
$0.00
|
| Weighted Average Shares Out Diluted |
$0.00
|
$0.00
|
$0.00
|
| Link |
|
|
|
